Innovation in Cardiology--and Beyond.
Executive Summary
For years, cardiovascular devices were the main focus of venture investors and the start-ups they backed. But in recent years, innovation in cardiovascular has grown more challenging, perhaps in part because of the way drug-eluting stents have reshaped the market, while other clinical spaces have opened up as promising technological and commercials opportunities. In this discussion, a distinguished group of physicians, product developers, and entrepreneurs look at where innovation is going and the challenges small companies face.